UnknownNot Applicable

Surgery With Extended (D3) Mesenterectomy for Small Bowel Tumors

Norway150 participantsStarted 2016-11-04

Plain-language summary

The study is designed to investigate the safety and efficacy of central D3 lymphadenectomy in cases of small bowel tumors. Such dissection is under debate; consensus guidelines are vague when it comes to surgical techniques and practice is highly variable.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients included must be able to fill in an informed, written consent and to understand its implications and contents and to participate in the follow-up * Radiologically/scintigraphically/histologically verified extraduodenal tumor(-s) in the small bowel and/or in the mesentery of the small bowel * No signs of inoperability * Fit for general anesthetics Exclusion Criteria: * Extraduodenal small bowel tumors verified as GIST or benign tumor * Widespread lymphoma

What they're measuring

Number of lymph nodes in total in D2 and D3 areas

Timeframe: 1 month

Number of positive lymph nodes in D2 and D3 areas

Timeframe: 1 month

Trial details

NCT IDNCT05670574

SponsorSykehuset i Vestfold HF

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-12-31

Contact for this trial

Dejan Ignjatovic, MD PhD

+4767969895 dejan.ignjatovic@ahus.no

View on ClinicalTrials.gov More Small Bowel Cancer trials